ALUR

Allurion Technologies, Inc. is a medical technology company focused on weight loss and obesity treatment through its proprietary intragastric balloon system. The company's flagship product is designed to be swallowed as a capsule and inflated in the stomach without requiring endoscopy, surgery, or anesthesia, providing a minimally invasive approach to weight management. The balloon occupies space in the stomach to promote satiety and reduce food intake, and is naturally passed after approximately four months. Allurion's platform also includes a connected scale, health tracker, and mobile app that enable patients and healthcare providers to monitor progress. The company serves patients through a network of clinics and healthcare professionals worldwide. Founded in 2009 and headquartered in Natick, Massachusetts, Allurion operates in the growing obesity treatment market driven by rising global obesity rates and demand for non-surgical interventions. The company competes with pharmaceutical weight loss treatments, bariatric surgery, and other medical devices while expanding market access and building clinical evidence for its technology.